CA
NZ
UK
AU
IND
US
Future Vision II Acquisition Corp. filed a Form 8-K on November 9, 2026, disclosing that it received written notification from Nasdaq on November 5, 2026, confirming it had regained compliance with the minimum public holders requirement for continued listing on The Nasdaq Capital Market.
CDT Equity Inc. filed a Form 8-K on November 9, 2026, disclosing that Dr. Andrew Regan, the company's former CEO, delivered a letter on November 5, 2026, on behalf of Corvus Capital Limited, stating an intent to make a non-binding proposal to acquire all …
CVR Energy, Inc. filed a Form 8-K on November 9, 2026, disclosing that the company held a meeting with potential lenders on that date to discuss a proposed Term Loan B secured credit facility.
Onconetix, Inc. filed a Form 8-K on November 9, 2026, disclosing that its previously approved one-for-ten reverse stock split of its common stock became effective at 12:01 a.m. Eastern Time on November 6, 2026.
Quanome Technologies, Inc. filed a Form 8-K on November 9, 2026, disclosing a Stock Purchase Agreement dated November 4, 2026, under which the company agreed to acquire 31,579 newly issued shares of QAI Labs Ltd. in exchange for 6,541,236 newly issued shares of Quanome …
CNH Industrial N.V. filed a current report on Form 8-K on November 9, 2026, disclosing that it entered into a Transaction Agreement to sell a 70% interest in its Construction Equipment business to Kobelco Construction Machinery Co., Ltd. and an affiliated U.S. entity, with …
WhiteHorse Finance, Inc. filed a Form 8-K with the SEC on November 9, 2026, announcing a quarterly distribution and its financial results for the third quarter ended September 30, 2026.
CL Workshop Group Limited filed a Form 6-K on November 9, 2026, disclosing the termination of its engagement with independent auditor WWC, P.C. and the appointment of Harmony CPA LLP as its new independent auditor, both effective the same date.
Agora, Inc. Chief Executive Officer and Director Zhao Bin filed a Form 4 on November 6, 2026, disclosing three open-market purchases of American Depositary Shares between November 4 and November 6, 2026, all made indirectly through YY TZ Limited pursuant to a Rule 10b5-1 …
Orthofix Medical Inc. filed an 8-K with the U.S. Securities and Exchange Commission on November 9, 2026, disclosing its financial results for the third quarter ended September 30, 2026, through a press release furnished as Exhibit 99.1.
Please wait processing your request...